This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1994.
Company Filing History:
1 out of 834,411 Years Active: 1994
Title: The Innovations of Per Borup-Christensen
Introduction
Per Borup-Christensen is a notable inventor based in Roslev, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for cancer research and treatment, showcasing the importance of innovation in medical science.
Latest Patents
Per Borup-Christensen holds a patent for a monoclonal antibody specific for a human tumour-associated antigen. This invention represents a crucial advancement in targeted therapies for cancer patients. The patent highlights his commitment to improving healthcare through innovative solutions.
Career Highlights
Throughout his career, Per Borup-Christensen has focused on the intersection of immunology and oncology. His research has contributed to a deeper understanding of tumor-associated antigens, paving the way for new therapeutic approaches. His dedication to scientific inquiry has established him as a respected figure in his field.
Collaborations
Per has collaborated with esteemed colleagues such as Jens Christian Jensenius and Karin Erb. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.
Conclusion
In summary, Per Borup-Christensen is a distinguished inventor whose work in monoclonal antibodies has the potential to transform cancer treatment. His innovative spirit and collaborative efforts continue to inspire advancements in medical science.